# Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab

> **NCT00605943** · — · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 30 (—)

## Conditions studied

- Macular Degeneration

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00605943
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-16
- **Primary completion:** 2009-08-04
- **Final completion:** 2009-08-04
- **Target enrollment:** 30 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605943, "Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00605943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*